These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1707418)

  • 1. Recovery of CD3+ and CD5- lymphocyte subpopulation after autologous bone marrow transplantation and chemotherapy.
    McKay PJ; McLaren A; Andrews LM; Lucie NP
    J Clin Pathol; 1991 Mar; 44(3):259-61. PubMed ID: 1707418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5-T lymphocytes in renal transplant recipients.
    McKay PJ; Kyle B; McLaren A; McMillan MA; Lucie NP
    Clin Lab Haematol; 1991; 13(4):335-40. PubMed ID: 1723035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of normal human CD3+ CD5- and gamma delta T cell receptor positive T lymphocytes.
    Spour EF; Leemhuis T; Jenski L; Redmond R; Fillak D; Jansen J
    Clin Exp Immunol; 1990 Apr; 80(1):114-21. PubMed ID: 1691061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large proportion of T lymphocytes lack CD5 expression after bone marrow transplantation.
    Bierer BE; Burakoff SJ; Smith BR
    Blood; 1989 Apr; 73(5):1359-66. PubMed ID: 2467708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mlsa generated suppressor cells. I. Suppression is mediated by double-negative (CD3+CD5+CD4-CD8-) alpha/beta T cell receptor-bearing cells.
    Bruley-Rosset M; Miconnet I; Canon C; Halle-Pannenko O
    J Immunol; 1990 Dec; 145(12):4046-52. PubMed ID: 1701781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo radiation resistance associated with CD3 surface antigen expression in T-lineage acute lymphoblastic leukemia.
    Uckun FM; Ramsay NK; Waddick KG; Jaszcz W; Chandan-Langlie M; Obuz V; Haake R; Gajl-Peczalska K; Kersey JH; Song CW
    Blood; 1991 Dec; 78(11):2945-55. PubMed ID: 1835411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow.
    Drobyski WR; Piaskowski V; Ash RC; Casper JT; Truitt RL
    Transplantation; 1990 Oct; 50(4):625-32. PubMed ID: 1699309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression and function of CD3 and CD5 in patients with primary Sjögren's syndrome.
    Dauphinée MJ; Tovar Z; Ballester A; Talal N
    Arthritis Rheum; 1989 Apr; 32(4):420-9. PubMed ID: 2468337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation.
    Soiffer RJ; Bosserman L; Murray C; Cochran K; Daley J; Ritz J
    Blood; 1990 May; 75(10):2076-84. PubMed ID: 1970938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease.
    Sakamoto H; Michaelson J; Jones WK; Bhan AK; Abhyankar S; Silverstein M; Golan DE; Burakoff SJ; Ferrara JL
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10890-4. PubMed ID: 1835792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of CD3 and CD5 donor T cell depletion on graft-versus-leukemia in a murine model for MHC-matched unrelated-donor transplantation.
    Okunewick JP; Kociban DL; Machen LL; Buffo MJ
    Bone Marrow Transplant; 1994 Jan; 13(1):11-7. PubMed ID: 7517254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of protection from graft-versus-host disease mortality by IL-2. III. Early reductions in donor T cell subsets and expansion of a CD3+CD4-CD8- cell population.
    Abraham VS; Sachs DH; Sykes M
    J Immunol; 1992 Jun; 148(12):3746-52. PubMed ID: 1534824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
    Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
    Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathology of early graft-versus-host disease--a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients.
    Sviland L; Pearson AD; Green MA; Baker BD; Eastham EJ; Reid MM; Hamilton PJ; Proctor SJ; Malcolm AJ
    Transplantation; 1991 Dec; 52(6):1029-36. PubMed ID: 1836284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG; Uckun FM
    Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients.
    Przepiorka D; Chan KW; Champlin RE; Culbert SJ; Petropoulos D; Ippoliti C; Khouri I; Huh YO; Vreisendorp H; Deisseroth AB
    Bone Marrow Transplant; 1995 Dec; 16(6):737-41. PubMed ID: 8750262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
    Soiffer RJ; Weller E; Alyea EP; Mauch P; Webb IL; Fisher DC; Freedman AS; Schlossman RL; Gribben J; Lee S; Anderson KC; Marcus K; Stone RM; Antin JH; Ritz J
    J Clin Oncol; 2001 Feb; 19(4):1152-9. PubMed ID: 11181681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD5-positive B cells after T cell depleted bone marrow transplantation.
    Drexler HG; Brenner MK; Wimperis JZ; Gignac SM; Janossy G; Prentice HG; Hoffbrand AV
    Clin Exp Immunol; 1987 Jun; 68(3):662-8. PubMed ID: 3308220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia.
    Lowdell MW; Craston R; Ray N; Koh M; Galatowicz G; Prentice HG
    Bone Marrow Transplant; 1998 Apr; 21(7):679-86. PubMed ID: 9578307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.